glp 1 seizures Newer glucose‐lowering drugs reduce the risk of late‐onset seizure and epilepsy: A meta‐analysis - Sindhu - 2024 - Epilepsia Open Frontiers | GLP−1 receptor agonists

Danese S, Motte Cd Cde L, Fiocchi C

But for some, it remains disruptive enough to cause dose reductions or treatment discontinuation

The story of GLP-1 fits perfectly within this

concerning How to eat, hydrate, and supplement properly How GLP-1s interact with hormones, insulin, and metabolism What to expect at each stage of the journey Informed patients are more consistent, more confident, and more successful

Nevertheless, understanding GI adverse events across both earlier and newer GLP-1based therapies remains highly relevant, particularly as these agents are increasingly prescribed for long-term and off-label indications

In patients treated with GLP-1RAs and tirzepatide, gastrointestinal side effects such as nausea and vomiting are common but do not significantly contribute to weight loss